The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Nov. 10, 2021
Applicant:

Ildong Pharmaceutical Co., Ltd., Seoul, KR;

Inventors:

Jae-Hoon Kang, Seoul, KR;

Hong-Sub Lee, Gyeonggi-do, KR;

Kyung-Mi An, Gunpo-si, KR;

Chang-Hee Hong, Seoul, KR;

Hyun-Jung Kwak, Suwon-si, KR;

Shuo-Lin Cui, Hwaseong-si, KR;

Hyo-Jung Song, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/12 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 409/12 (2013.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01);
Abstract

Compounds of Formula (I), racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions containing the compounds, racemates, enantiomers, diastereomers thereof are disclosed. These compounds have GPR40 agonist activity and are capable of modulating blood glucose levels and glucose-dependent insulin secretion mechanism, and, thus, exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. These compounds could be used in preventing and/or treating type 2 diabetes through adequate control of blood glucose.


Find Patent Forward Citations

Loading…